carbamates has been researched along with Dysplastic Nevus Syndrome, Hereditary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kattan, J | 1 |
| Kattan, C | 1 |
| Farhat, F | 1 |
| Assi, T | 1 |
| Ramtohul, P | 1 |
| Denis, D | 1 |
| Comet, A | 1 |
| Russo, I | 1 |
| Zorzetto, L | 1 |
| Frigo, AC | 1 |
| Chiarion Sileni, V | 1 |
| Alaibac, M | 1 |
3 other studies available for carbamates and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
Overcoming the resistance to BRAF inhibitor by the double BRAF and MEK inhibitions in advanced melanoma: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carbamates; Drug Resistance, Neoplas | 2019 |
Kinetics of Punctate Subretinal Deposits in Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy Using En Face Optical Coherence Tomography.
Topics: Acrylonitrile; Adult; Aniline Compounds; Carbamates; Extracellular Signal-Regulated MAP Kinases; Flu | 2021 |
A comparative study of the cutaneous side effects between BRAF monotherapy and BRAF/MEK inhibitor combination therapy in patients with advanced melanoma: a single-centre experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carbamates; Humans; Imidazole | 2017 |